Abrdn Life Sciences Investors HQL Stock
Abrdn Life Sciences Investors Price Chart
Abrdn Life Sciences Investors HQL Financial and Trading Overview
Abrdn Life Sciences Investors stock price | 12.16 USD |
Previous Close | 13.71 USD |
Open | 13.71 USD |
Bid | 12.78 USD x 1400 |
Ask | 0 USD x 800 |
Day's Range | 13.67 - 13.88 USD |
52 Week Range | 13.07 - 16.33 USD |
Volume | 153.26K USD |
Avg. Volume | 67.02K USD |
Market Cap | 362.77M USD |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | 138.4 |
EPS (TTM) | 3.04 USD |
Forward Dividend & Yield | 1.28 (9.33%) |
Ex-Dividend Date | May 24, 2023 |
1y Target Est | N/A |
HQL Valuation Measures
Enterprise Value | 352.07M USD |
Trailing P/E | 138.4 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.8931914 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Abrdn Life Sciences Investors Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | 2.59% |
S&P500 52-Week Change | 20.43% |
52 Week High | 16.33 USD |
52 Week Low | 13.07 USD |
50-Day Moving Average | 13.81 USD |
200-Day Moving Average | 14.23 USD |
HQL Share Statistics
Avg. Volume (3 month) | 67.02K USD |
Avg. Daily Volume (10-Days) | 88.97K USD |
Shares Outstanding | 26.21M |
Float | N/A |
Short Ratio | 0.15 |
% Held by Insiders | 0.0030% |
% Held by Institutions | 20.56% |
Shares Short | 9.31K |
Short % of Float | N/A |
Short % of Shares Outstanding | 0.040% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | 896.00% |
Payout Ratio | 13 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | September 30, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | September 30, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | 0.12 USD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | 3.02M USD |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | 0.1 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 15.495 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Abrdn Life Sciences Investors
Country | United States |
State | MA |
City | Boston |
Address | 100 Federal Street |
ZIP | 02110 |
Phone | 617 772 8500 |
Website | https://www.teklacap.com/hql.html |
Industry | Asset Management |
Sector(s) | Financial Services |
Full Time Employees | N/A |
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Q&A For Abrdn Life Sciences Investors Stock
What is a current HQL stock price?
Abrdn Life Sciences Investors HQL stock price today per share is 12.16 USD.
How to purchase Abrdn Life Sciences Investors stock?
You can buy HQL shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Abrdn Life Sciences Investors?
The stock symbol or ticker of Abrdn Life Sciences Investors is HQL.
Which industry does the Abrdn Life Sciences Investors company belong to?
The Abrdn Life Sciences Investors industry is Asset Management.
How many shares does Abrdn Life Sciences Investors have in circulation?
The max supply of Abrdn Life Sciences Investors shares is 28.06M.
What is Abrdn Life Sciences Investors Price to Earnings Ratio (PE Ratio)?
Abrdn Life Sciences Investors PE Ratio is 4.00000000 now.
What was Abrdn Life Sciences Investors earnings per share over the trailing 12 months (TTM)?
Abrdn Life Sciences Investors EPS is 3.04 USD over the trailing 12 months.
Which sector does the Abrdn Life Sciences Investors company belong to?
The Abrdn Life Sciences Investors sector is Financial Services.
Abrdn Life Sciences Investors HQL included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE COMPOSITE (DJ) NYA | 18767.19 USD — |
-3.92
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}